ARCH VENTURE PARTNERS
ARCH invests primarily in companies co-founded by scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories. ARCH has raised ten venture funds totaling over $3 billion and has invested in the earliest venture capital rounds for more than 150 companies. ARCH investors include major corporations, pension funds, endowment funds, financial institutions, and private investors.
ARCH VENTURE PARTNERS
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
1986-01-01
Status:
Active
Contact:
773-380-6600
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Autobahn Therapeutics | ARCH Venture Partners investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
| 2022-09-07 | Orbital Therapeutics | ARCH Venture Partners investment in Seed Round - Orbital Therapeutics | N/A |
| 2022-09-06 | Elephas | ARCH Venture Partners investment in Series B - Elephas | 41.5 M USD |
| 2022-08-29 | Vilya | ARCH Venture Partners investment in Series A - Vilya | 50 M USD |
| 2022-08-24 | Happy Health | ARCH Venture Partners investment in Series A - Happy Health | 60 M USD |
| 2022-08-03 | Homeward | ARCH Venture Partners investment in Series B - Homeward | 50 M USD |
| 2022-08-02 | Sironax | ARCH Venture Partners investment in Series B - Sironax | 200 M USD |
| 2022-07-12 | Areteia Therapeutics | ARCH Venture Partners investment in Series A - Areteia Therapeutics | 350 M USD |
| 2022-06-03 | Vizgen | ARCH Venture Partners investment in Series C - Vizgen | 85.2 M USD |
| 2022-05-17 | Remix Therapeutics | ARCH Venture Partners investment in Series B - Remix Therapeutics | 70 M USD |